Is there still an indication for prescribing blood sedimentation in primary care? Volume 18, issue 4, April 2022


  • Figure 1.
Université Jean Monnet, Faculté de médecine Jacques Lisfranc, département de médecine générale, Campus santé innovations, 42270 Saint Priest en Jarez
* Correspondance : A. Falcon

The blood sedimentation (BS) was a basic test for general practitioners at the end of the 20th century as a marker of inflammation. Today, the BS is still widely used, as evidenced by the 14 million determinations in ambulatory medicine in 2018. However, the BS is a non-specific marker that is now competing with other more efficient assays. A systematic review of the literature was carried out between 30 March 2020 and 30 January 2022 as well as an analysis of the recommendations of learned societies. Evidence Based Medicine does not justify the use of the blood sedimentation rate in general practice (even if it remains possible in a few rare situations: Horton, Hodgkin, rheumatoid arthritis). The limited scientific literature on the use of the BS in general practice and its gradual disappearance from the guidelines of learned societies justifies the cessation of the use of this assay in general practice.